Literature DB >> 9784543

Complement activation in relation to capillary leakage in children with septic shock and purpura.

J A Hazelzet1, R de Groot, G van Mierlo, K F Joosten, E van der Voort, A Eerenberg, M H Suur, W C Hop, C E Hack.   

Abstract

To assess the relationship between capillary leakage and inflammatory mediators during sepsis, blood samples were taken on hospital admission, as well as 24 and 72 h later, from 52 children (median age, 3.3 years) with severe meningococcal sepsis, of whom 38 survived and 14 died. Parameters related to cytokines (interleukin 6 [IL-6] IL-8, plasma phospholipase A2, and C-reactive protein [CRP]), to neutrophil degranulation (elastase and lactoferrin), to complement activation (C3a, C3b/c, C4b/c, and C3- and C4-CRP complexes), and to complement regulation (functional and inactivated C1 inhibitor and C4BP) were determined. The degree of capillary leakage was derived from the amount of plasma infused and the severity of disease by assessing the pediatric risk of mortality (PRISM) score. Levels of IL-6, IL-8, C3b/c, C3-CRP complexes, and C4BP on admission, adjusted for the duration of skin lesions, were significantly different in survivors and nonsurvivors (C3b/c levels were on average 2.2 times higher in nonsurvivors, and C3-CRP levels were 1.9 times higher in survivors). Mortality was independently related to the levels of C3b/c and C3-CRP complexes. In agreement with this, levels of complement activation products correlated well with the PRISM score or capillary leakage. Thus, these data show that complement activation in patients with severe meningococcal sepsis is associated with a poor outcome and a more severe disease course. Further studies should reveal whether complement activation may be a target for therapeutical intervention in this disease.

Entities:  

Mesh:

Year:  1998        PMID: 9784543      PMCID: PMC108669     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway.

Authors:  G J Wolbink; J Bollen; J W Baars; R J ten Berge; A J Swaak; J Paardekooper; C E Hack
Journal:  J Immunol Methods       Date:  1993-07-06       Impact factor: 2.303

2.  Pediatric risk of mortality (PRISM) score.

Authors:  M M Pollack; U E Ruttimann; P R Getson
Journal:  Crit Care Med       Date:  1988-11       Impact factor: 7.598

Review 3.  Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  P Densen
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

4.  Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis.

Authors:  C E Hack; J H Nuijens; R J Felt-Bersma; W O Schreuder; A J Eerenberg-Belmer; J Paardekooper; W Bronsveld; L G Thijs
Journal:  Am J Med       Date:  1989-01       Impact factor: 4.965

5.  A modified competitive inhibition radioimmunoassay for the detection of C3a. Use of 125I-C3 instead of 125I-C3a.

Authors:  C E Hack; J Paardekooper; A J Eerenberg; G O Navis; M W Nijsten; L G Thijs; J H Nuijens
Journal:  J Immunol Methods       Date:  1988-04-06       Impact factor: 2.303

6.  A rate nephelometer for measuring specific proteins by immunoprecipitin reactions.

Authors:  J C Sternberg
Journal:  Clin Chem       Date:  1977-08       Impact factor: 8.327

7.  Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern.

Authors:  J P de Boer; A A Creasey; A Chang; D Roem; A J Eerenberg; C E Hack; F B Taylor
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Low prevalence of complement deficiencies among patients with meningococcal disease in Norway.

Authors:  K Høgåsen; T Michaelsen; O J Mellbye; G Bjune
Journal:  Scand J Immunol       Date:  1993-04       Impact factor: 3.487

Review 9.  Interplay of complement and cytokines in the pathogenesis of septic shock.

Authors:  J P de Boer; G J Wolbink; L G Thijs; J W Baars; J Wagstaff; C E Hack
Journal:  Immunopharmacology       Date:  1992 Sep-Oct

10.  Complement abnormalities during an epidemic of group B meningococcal infection in children.

Authors:  D W Beatty; C R Ryder; H D Heese
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

View more
  15 in total

Review 1.  The immunopathogenesis of meningococcal disease.

Authors:  A J Kvalsvig; D J Unsworth
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

2.  Stages of meningococcal sepsis simulated in vitro, with emphasis on complement and Toll-like receptor activation.

Authors:  Bernt Christian Hellerud; Jørgen Stenvik; Terje Espevik; John D Lambris; Tom Eirik Mollnes; Petter Brandtzaeg
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

3.  Global Case-Fatality Rates in Pediatric Severe Sepsis and Septic Shock: A Systematic Review and Meta-analysis.

Authors:  Bobby Tan; Judith Ju-Ming Wong; Rehena Sultana; Janine Cynthia Jia Wen Koh; Mark Jit; Yee Hui Mok; Jan Hau Lee
Journal:  JAMA Pediatr       Date:  2019-04-01       Impact factor: 16.193

Review 4.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

5.  Elastase and granzymes during meningococcal disease in children: correlation to disease severity.

Authors:  Job B M van Woensel; Maarten H Biezeveld; C Erik Hack; Albert P Bos; Taco W Kuijpers
Journal:  Intensive Care Med       Date:  2005-07-12       Impact factor: 17.440

6.  Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge.

Authors:  Irene Bosch; Kris Xhaja; Luis Estevez; Gregory Raines; Heather Melichar; Rajas V Warke; Marcia V Fournier; Francis A Ennis; Alan L Rothman
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

Review 7.  C1 inhibitor: molecular and clinical aspects.

Authors:  Marco Cicardi; Lorenza Zingale; Andrea Zanichelli; Emanuela Pappalardo; Benedetta Cicardi
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

8.  Neisseria meningitidis Opc invasin binds to the sulphated tyrosines of activated vitronectin to attach to and invade human brain endothelial cells.

Authors:  Claudia Sa E Cunha; Natalie J Griffiths; Mumtaz Virji
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

9.  Administration of C1 inhibitor reduces neutrophil activation in patients with sepsis.

Authors:  Sacha Zeerleder; Christoph Caliezi; Gerard van Mierlo; Anke Eerenberg-Belmer; Irmela Sulzer; C Erik Hack; Walter A Wuillemin
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

10.  Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide.

Authors:  Tom Sprong; Anne-Sophie W Møller; Anna Bjerre; Elisabeth Wedege; Peter Kierulf; Jos W M van der Meer; Petter Brandtzaeg; Marcel van Deuren; T E Mollnes
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.